<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-10-28 07:38:04Tyrosine kinase receptors Pharmacology Ribbon symbolism Monoclonal antibodies Immunology HER2/neu Trastuzumab Targeted therapy Pertuzumab Medicine Bristol-Myers Squibb Biology |
|
Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy (NEW YORK and CAMBRIDGE, UK – October 28, Bristol-Myers Squibb Compa